Process for producing wine lactone
Abstract
The present invention relates to a method comprising (A) reacting a β-keto ester with a 2-halo ester under basic conditions to obtain a 2-aceto-3-methyl-succinic acid ester; (B) reacting the resulting 2-aceto-3-methyl-succinic acid ester with methyl vinyl ketone under basic conditions, optionally followed by a decarboxylation reaction and hydrolysis, etc., to obtain an α-methyl-γ-keto acid; and (C) reducing the resulting α-methyl-γ-keto acid to obtain wine lactone or a stereoisomer thereof or a mixture thereof. Alternatively, the present invention relates to a method comprising step (A) as recited above; (B) reacting the resulting 2-aceto-3-methyl-succinic acid ester with methyl vinyl ketone under basic conditions, followed by decarboxylation reaction to obtain an α-methyl-γ-keto acid ester; and (E) reducing the resulting α-methyl-γ-keto acid ester in the presence of a ruthenium complex having a specific structure and in the presence of a hydrogen donor to obtain wine lactone or a stereoisomer thereof or a mixture thereof.
Claims
exact text as granted — not AI-modified1 . A process for producing a compound represented by formula (a), which is wine lactone or a stereoisomer thereof or a mixture thereof:
wherein said process comprises:
A) the step of reacting a β-keto ester represented by formula (1):
[wherein R 1 is an alkyl group containing 1 to 4 carbon atoms]
with a 2-halo ester represented by formula (2):
[wherein R 2 is an alkyl group containing 1 to 4 carbon atoms, and X is a chlorine atom or a bromine atom]
under basic conditions to obtain a 2-aceto-3-methyl-succinic acid ester represented by formula (3):
[wherein R 1 is as defined in formula (1), and R 2 is as defined in formula (2)];
B-2) the step of reacting the 2-aceto-3-methyl-succinic acid ester obtained in step A) with methyl vinyl ketone under basic conditions, followed by decarboxylation reaction to obtain an α-methyl-γ-keto acid ester represented by formula (5):
[wherein R 2 is as defined in formula (2)];
B-3) the step of hydrolyzing the α-methyl-γ-keto acid ester obtained in step B-2) to obtain an α-methyl-γ-keto acid represented by formula (4):
and
C) the step of reducing the α-methyl-γ-keto acid obtained in step B-3) to obtain the compound represented by formula (a).
2 . The process according to claim 1 , wherein step C) comprises causing asymmetric reduction reaction in the presence of an optically active form of a ruthenium complex selected from compounds represented by formula (6) or (7) and in the presence of a hydrogen donor:
[wherein * represents an asymmetric carbon atom,
R 31 is an alkyl group containing 1 to 10 carbon atoms; a halogenated alkyl group containing 1 to 10 carbon atoms; a 10-camphoryl group; an amino group which may be substituted with one or two alkyl groups each containing 1 to 10 carbon atoms; or an aryl group which may be substituted with at least one substituent selected from the group consisting of an alkyl group containing 1 to 10 carbon atoms, a halogenated alkyl group containing 1 to 10 carbon atoms, a halogen atom, a cyano group (—CN), an amino group, an alkylamino group (—NR 20 R 21 ) a 5- or 6-membered cyclic amino group, an acylamino group (—NH—CO—R 20 ), a hydroxyl group, an alkoxy group (—OR 20 ), an acyl group (—CO—R 20 ), a carboxyl group, an alkoxycarbonyl group (—COOR 20 ), a phenoxycarbonyl group, a mercapto group, an alkylthio group (—SR 20 ), a silyl group (—SiR 20 R 21 R 22 ) and a nitro group (—NO 2 ), wherein R 20 , R 21 and R 22 are each independently a hydrogen atom, an alkyl group containing 1 to 10 carbon atoms, or a cycloalkyl group containing 3 to 10 carbon atoms,
Y is a hydrogen atom,
W is a trifluoromethanesulfonyloxy group, a p-toluenesulfonyloxy group, a methanesulfonyloxy group, a benzenesulfonyloxy group, a hydrogen atom, or a halogen atom,
j and k are each independently 0 or 1, provided that j+k is not 1,
R 32 and R 33 are each independently a hydrogen atom; an alkyl group containing 1 to 10 carbon atoms; a phenyl group which may be substituted with at least one substituent selected from the group consisting of an alkyl group containing 1 to 10 carbon atoms, an alkoxy group containing 1 to 10 carbon atoms and a halogen atom; or a cycloalkyl group containing 3 to 8 carbon atoms, or alternatively, R 32 and R 33 may together form a ring,
R 11 , R 12 , R 13 , R 14 and R 15 each independently represent a hydrogen atom, an alkyl group containing 1 to 10 carbon atoms, or an alkoxy group containing 1 to 10 carbon atoms,
R 16 , R 17 , R 18 and R 19 are each independently a hydrogen atom, a hydroxyl group, an alkyl group containing 1 to 10 carbon atoms, or an alkoxy group containing 1 to 10 carbon atoms, or alternatively, R 16 and R 17 may form a carbonyl group together with their adjacent carbon atom and/or R 18 and R 19 may form a carbonyl group together with their adjacent carbon atom,
Z is an oxygen atom or a sulfur atom,
n 1 is 1 or 2, and n 2 is an integer of 1 to 3]
[wherein * represents an asymmetric carbon atom,
R 31 is an alkyl group containing 1 to 10 carbon atoms; a halogenated alkyl group containing 1 to 10 carbon atoms; a 10-camphoryl group; an amino group which may be substituted with one or two alkyl groups each containing 1 to 10 carbon atoms; or an aryl group which may be substituted with at least one substituent selected from the group consisting of an alkyl group containing 1 to 10 carbon atoms, a halogenated alkyl group containing 1 to 10 carbon atoms, a halogen atom, a cyano group (—CN), an amino group, an alkylamino group (—NR 20 R 21 ) a 5- or 6-membered cyclic amino group, an acylamino group (—NH—CO—R 20 ), a hydroxyl group, an alkoxy group (—OR 20 ), an acyl group (—CO—R 20 ), a carboxyl group, an alkoxycarbonyl group (—COOR 20 ), a phenoxycarbonyl group, a mercapto group, an alkylthio group (—SR 20 ), a silyl group (—SiR 20 R 21 R 22 ) and a nitro group (—NO 2 ),
R 20 , R 21 and R 22 are each independently a hydrogen atom, an alkyl group containing 1 to 10 carbon atoms, or a cycloalkyl group containing 3 to 10 carbon atoms,
Y is a hydrogen atom,
R 32 and R 33 are each independently a hydrogen atom; an alkyl group containing 1 to 10 carbon atoms; a phenyl group which may be substituted with at least one substituent selected from the group consisting of an alkyl group containing 1 to 10 carbon atoms, an alkoxy group containing 1 to 10 carbon atoms and a halogen atom; or a cycloalkyl group containing 3 to 8 carbon atoms, or alternatively, R 32 and R 33 may together form a ring,
R 11 , R 12 , R 13 , R 14 and R 15 are each independently a hydrogen atom, an alkyl group containing 1 to 10 carbon atoms, or an alkoxy group containing 1 to 10 carbon atoms,
R 16 , R 17 , R 18 and R 19 are each independently a hydrogen atom, a hydroxyl group, an alkyl group containing 1 to 10 carbon atoms, or an alkoxy group containing 1 to 10 carbon atoms, or alternatively, R 16 and R 17 may form a carbonyl group together with their adjacent carbon atom and/or R 18 and R 19 may form a carbonyl group together with their adjacent carbon atom,
Z is an oxygen atom or a sulfur atom, Q − is a counter anion,
n 1 is 1 or 2, and n 2 is an integer of 1 to 3].
3 . The process according to claim 2 , wherein the ruthenium complex represented by formula (6) is a compound represented by the following formula:
4 . The process according to claim 1 , which further comprises the step of distilling the compound obtained in step C) under basic conditions to obtain a diastereomeric isomer mixture composed of (3S,3aS,7aR) and (3R,3aR,7aS) isomers represented by the following formulae:
5 . The process according to claim 2 , which further comprises the step of distilling the compound obtained in step C) under basic conditions to obtain a diastereomeric isomer mixture composed of (3S,3aS,7aR) and (3R,3aR,7aS) isomers represented by the following formulae:
6 . The process according to claim 5 , which further comprises the step of recrystallization to obtain the (3S,3aS,7aR) isomer represented by the following formula:
7 . The process according to claim 3 , wherein in step E), the ruthenium complex selected from compounds represented by formula (6) or (7) is an optically active ruthenium complex and is used to cause asymmetric reduction reaction.Join the waitlist — get patent alerts
Track US2013245287A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.